Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
CytRx reaches targeted enrollment in aldoxorubicin Phase 2b study for treatment of soft tissue sarcoma

CytRx reaches targeted enrollment in aldoxorubicin Phase 2b study for treatment of soft tissue sarcoma

Investigators uncover connection between tumor metabolic process and progression of kidney cancer

Investigators uncover connection between tumor metabolic process and progression of kidney cancer

Research findings suggest potent new therapeutic target for certain types of cancer

Research findings suggest potent new therapeutic target for certain types of cancer

TSRI scientists receive NIH grant to create new drug for chronic lymphocytic leukemia

TSRI scientists receive NIH grant to create new drug for chronic lymphocytic leukemia

Ibrutinib shows remarkable promise for treatment of mantle cell lymphoma

Ibrutinib shows remarkable promise for treatment of mantle cell lymphoma

Results of ibrutinib Phase 2 study in patients with mantle cell lymphoma published in NEJM

Results of ibrutinib Phase 2 study in patients with mantle cell lymphoma published in NEJM

MCL-1 protein is vital for normal heart function, shows study

MCL-1 protein is vital for normal heart function, shows study

Targeting SALL4 protein with druglike molecules could halt tumor growth, say researchers

Targeting SALL4 protein with druglike molecules could halt tumor growth, say researchers

RetroNectin reagent now available for gene therapy clinical research

RetroNectin reagent now available for gene therapy clinical research

Genmab, ADC Therapeutics agree to develop new antibody-drug conjugate product

Genmab, ADC Therapeutics agree to develop new antibody-drug conjugate product

European Commission amends marketing authorisation for Celgene's REVLIMID

European Commission amends marketing authorisation for Celgene's REVLIMID

Ibrutinib monotherapy shows efficacy in patients with MCL or DLBCL

Ibrutinib monotherapy shows efficacy in patients with MCL or DLBCL

CSHL scientists solve the mystery of why some infants born with grave syndrome

CSHL scientists solve the mystery of why some infants born with grave syndrome

Mount Sinai researchers produce cells that resemble hematopoietic stem cells

Mount Sinai researchers produce cells that resemble hematopoietic stem cells

PRISM Pharma announces closing of $15 million Series C financing

PRISM Pharma announces closing of $15 million Series C financing

Research could enable early screening of liver cancer patients to improve survival rate

Research could enable early screening of liver cancer patients to improve survival rate

Study provides complete health picture of adult survivors of childhood cancer

Study provides complete health picture of adult survivors of childhood cancer

ARIAD Pharmaceuticals initiates ponatinib Phase 2 trial in adult patients with metastatic GIST

ARIAD Pharmaceuticals initiates ponatinib Phase 2 trial in adult patients with metastatic GIST

CT scans increase risk of radiation-induced cancer in young children, study finds

CT scans increase risk of radiation-induced cancer in young children, study finds

Cytosine methylation plays key role in development of childhood ALL

Cytosine methylation plays key role in development of childhood ALL

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.